What sustained mental health demand, a federal funding pullback, and a deepening provider shortage mean for healthcare organizations and the behavioral health market.
May is Mental Health Awareness Month: a moment to recognize both how far awareness has come, and how much work remains ahead.
More Americans are living with mental illness and substance use disorders, while treatment capacity continues to lag demand. At the same time, the behavioral health system is facing its steepest climb as federal support contracts alongside persistent gaps in access.
For health systems, biopharma, and digital health companies, behavioral health has become both a growth area and an operational challenge shaped by these underlying constraints. What follows is a data-grounded look at eight trends defining the market in 2026 and where it’s heading next.
#1. Nearly 1 in 4 U.S. adults live with mental illness
In 2024, an estimated 61.5 million Americans, or about 1 in 4 adults, experienced some form of mental illness, according to the latest National Survey on Drug Use and Health (NSDUH). Of those, 14.6 million had a serious mental illness. At the same time, 48.4 million people aged 12+, or nearly 1 in 6, met criteria for a substance use disorder (SUD).
Behavioral health conditions remain steady in the U.S. population
Fig. 1 - Number of U.S. adults 18+ with any mental illness, by year, and number of people ages 12+ with a substance use disorder, by year. Source: 2024 NSDUH.
Implication: Despite modest year-to-year fluctuations, mental illness and SUD prevalence in the U.S. has remained largely stable, reflecting a persistent demand burden. With demand holding high, the constraint shifts from patient volume to system capacity, making access, retention, and continuity of care the binding limitations for providers and drug makers alike.
#2. Anxiety and depression account for most mental illness
Anxiety and depression account for the bulk of mental health burden in the U.S., according to the National Alliance on Mental Health (NAMI). Within this broader landscape, data from the NSDUH shows that 14.3 million adults (5.5%) reported serious thoughts of suicide in 2024, along with 2.6 million adolescents (10.1%), underscoring the level of acute need layered on top of ongoing, recurring behavioral health conditions for many patients.
Implication: Behavioral health demand is concentrated in a few common conditions, but it’s often delivered through fragmented, episodic encounters layered over long-term need, which can place sustained pressure on outpatient providers who must manage both routine care and crisis escalation.
Prevalence of mental illness among U.S. adults by condition
Fig. 2 - Annual prevalence of mental illness among U.S. adults by condition. Source: NAMI.
#3. Co-occurrence drives complexity in behavioral health care delivery
Among the 61.5 million adults with any mental illness, about a third (21.2 million people) also had a co-occurring substance use disorder. For those with serious mental illness, that figure climbs to nearly half. Co-occurring substance use further compounds behavioral health demand, adding complexity to treatment pathways and increasing the need for integrated or coordinated care models.
Mental illness and substance use disorder commonly co-occur
Fig. 3 - Number of U.S. adults 18+ with co-occurring any mental illness (AMI) and substance use disorder (SUD). Source: 2024 NSDUH.
Implication: Behavioral health is not a siloed specialty market. High co-occurrence between mental health conditions and substance use disorders has direct implications for treatment design, network configuration, care pathways, and how healthcare providers and biopharma understand, reach, and support patient populations.
#4. The treatment gap remains a core challenge
There’s a sustained gap between behavioral health need and care: in 2024, 61.5 million U.S. adults experienced any mental illness, and 52.1% (32.0 million people) received mental health treatment, leaving nearly 30 million without care.
The gap is wider in substance use disorder. Among individuals classified as needing treatment, only 19.3% (10.2 million people) received services in 2024, meaning more than 4 in 5 went untreated. Taken together, mental health and SUD utilization has remained relatively stable over time, but a substantial share of need continues to go unmet even in a high-prevalence environment.
Treatment receipt differs across mental health and SUDs
Fig. 4 – Share of behavioral health need receiving treatment by condition. Note: Any mental illness (AMI) and serious mental illness (SMI) include ages 18+. Substance use disorder (SUD) includes ages 12+. Co-occurring AMI and SUD includes receipt of either SUD or mental health treatment. Source: Analysis of 2024 NSDUH.
Implication: The gap between treatment need and receipt reflects, in part, structural constraints in access. For health systems and insurers, this can drive higher downstream acuity and cost. For life sciences, it highlights the importance of finding untreated populations earlier in the care continuum and understanding where engagement into treatment pathways breaks down.
#5. The provider shortage is growing
A big part of the treatment gap comes down to not having enough behavioral health providers to meet demand. About 137 million Americans, or 40% of the U.S. population, live in federally designated Mental Health Professional Shortage Areas (HPSAs), according to Kaiser Family Foundation (KFF) data.
HPSA designations estimate thousands of additional psychiatrists (about 6,800 nationwide) would be required to meet minimum population-to-provider thresholds that would remove these shortage designations, although actual workforce needs likely exceed this estimate.
However, projected workforce trends suggest demand will continue to outpace supply across multiple behavioral health roles, indicating that current gaps are likely to persist, and in some cases deepen, through the next decade.
Behavioral health workforce gaps by 2038
Fig. 5 - Projected supply and demand for selected behavioral health occupations in 2038, shown as percentage of need met and unmet. Source: Analysis of data from HRSA’s Health Workforce Simulation Model as of Dec. 18, 2025.
Geography further amplifies the problem. Behavioral health providers are concentrated in urban and affluent areas, while rural communities, small metros, and low-income urban neighborhoods often function as effective care deserts.
Scope-of-practice expansions, including broader buprenorphine prescribing authority, provide partial relief but don’t address the broader therapist and counselor shortage.
Implication: A geographically uneven and constrained provider base shifts the system from demand-driven growth to capacity-constrained delivery, where access, network design, and care pathways are increasingly determined by workforce availability and geographic distribution.
#6. Digital behavioral health is maturing
Digital behavioral health is entering a period of consolidation following pandemic-era growth.
Telehealth’s behavioral health expansion during the pandemic has proven durable, with a JAMA study showing utilization rising from 2.1% pre-pandemic to 54.4% of outpatient mental health claims during the pandemic and stabilizing at 42.9% post-pandemic, while overall utilization remained steady, indicating a largely substitutional shift in care delivery.
Digital-first platforms have achieved penetration through employer benefits, direct-to-consumer channels, and payor partnerships, but the market is now moving toward consolidation through acquisitions of point solutions by scaled incumbents, roll-ups in hybrid care delivery, and retrenchment among early high-growth entrants.
Recent examples include:
• Teladoc’s acquisition of UpLift
• Spring Health’s acquisition of Alma
• NOCD’s acquisition of Rebound Health
• Virtual Therapeutic’s acquisition of Aliki
These transactions are increasingly targeted, reflecting efforts to extend capabilities across the care continuum through specialty expansion and provider network infrastructure rather than scale alone. Spring Health’s acquisition of Alma, for example, adds in-network provider infrastructure and health plan relationships, expanding reach to more patients.
A further signal of durability is CMS’s Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model, launching in July 2026. It introduces outcomes-based payment for chronic condition management, including a dedicated behavioral health track. By incorporating telehealth, digital tools, and remote monitoring, it marks a step toward embedding digital behavioral health into Medicare payment infrastructure.
Implication: Digital behavioral health is maturing from a point-solution market into a consolidated care infrastructure layer. Competitive advantage is increasingly defined by payor integration, provider network access, and reimbursement alignment rather than standalone digital product differentiation. Companies that can improve outcomes, not just digital health usage or engagement, are likely to pull ahead.
#7. AI chatbots are filling a gap in mental health
About 1 in 6 adults report using AI tools for mental health information or advice in the past year, according to a recent KFF poll. These users most commonly say they’ve used AI to look up symptoms or general information about a mental health condition (11%) or to get advice or coping strategies for mental health issues (11%).
While not a substitute for clinical care, these tools appear to be absorbing demand for guidance that sits outside formal treatment, especially around symptom interpretation and day-to-day coping skills.
On one hand, AI may be extending access to basic mental health literacy and support in ways traditional systems often cannot scale. On the other, it signals a growing channel of care outside clinical pathways, raising questions around quality, safety, and continuity of care as more people use conversational AI in place of, or in addition to, professional treatment.
1 in 6 adults say they used AI tools for mental health
Fig. 6 – Percentage of U.S. adults who report using AI in the past year for mental health information or advice, by purpose. Source: 2026 KFF Tracking Poll on Health Information and Trust.
Implication: AI chatbots like ChatGPT and Google Gemini are becoming an informal front door to mental health care. Healthcare organizations should treat them as an emerging distribution channel for early-stage engagement, where demand is already forming around symptom interpretation, psychoeducation, and coping strategies outside clinical settings.
#8. Policy shifts are impacting providers’ ability to deliver care
Behavioral health had, for a stretch, benefited from bipartisan federal attention. The pandemic accelerated investment, parity enforcement took on renewed urgency, and the Substance Abuse and Mental Health Services Administration’s (SAMHSA) role expanded. That period appears to be coming to a close.
The One Big Beautiful Bill Act (OBBBA), as enacted, will implement the largest cuts to Medicaid in U.S. history, totaling roughly $1 trillion. Given Medicaid accounts for 25% of all spending on mental health and SUD treatment, these reductions are expected to have broad downstream effects on access to behavioral health care.
At the same time, the Trump administration moved to scale back funding for mental health and substance use programs, including more than $1 billion in proposed cuts to SAMHSA-related initiatives. This included reductions to block grants and the rollback of overdose prevention programs.
Staffing cuts and the abrupt cancellation of awarded grants, later reinstated, have left states and providers on unstable ground, creating a patchwork at the state level with uneven capacity to absorb uncertainty and backfill federal funding gaps.
The federal government is also scaling back behavioral health measurement systems. For example, HHS cut the entire scientific team responsible for the annual NSDUH survey. This may result in less visibility into how recent funding reductions and policy changes impact behavioral health care over time.
Implications: These policy changes mark a sharp shift in federal posture during a period of high need and are expected to carry uneven downstream effects across the behavioral health ecosystem:
- Providers: Community mental health centers and SUD programs with grant dependence face viability risk and shorter planning horizons, which could force narrower services lines and greater crisis-driven demand.
- Payors: As safety-net capacity erodes, Medicaid MCOs may absorb more high-acuity behavioral health utilization, raising total costs. Medicaid is the nation’s largest payor for mental health and substance use care.
- Biopharma: Thinner treatment infrastructure in affected markets may complicate patient identification and support program design, particularly as HHS signals a broader shift toward curbing psychiatric prescribing.
- Digital health: Companies with exposure to government funding or grant-supported programs could face increased revenue risk and repricing pressure, but the CMS ACCESS model also creates a more durable reimbursement pathway for tech-enabled behavioral health vendors.
See the behavioral health market clearly
Behavioral health opportunities aren’t evenly distributed across the market. Seeing it clearly—where access gaps persist, where capacity is growing, and how patients move through fragmented care pathways—is critical to knowing where to act.
Get the Definitive picture of the behavioral health market, and see how organizations are using real-world data and insights to close gaps and connect patients to care. Book a demo.
You might also be interested in...
